Community reports and its selectivity profile describe much less appetite stimulation than older GHRPs like GHRP-6
In 2025 alone, the combined global sales of Ozempic, Wegovy, and Rybelsus exceeded $48 billion and the 2026 projection is rising further as Wegovy overtakes Ozempic in the US market
Theophylline (Oral Route)
For most patients on GLP-1s, the question in the back of their minds is: Do I need to stay on this forever? Even after they've reached their weight loss goals, they worry that once they stop the medication, the hunger, weight gain, and food noise will come right back
2020;17:e1003082
Preventing Weight Regain : Sustained Progress : By continuing your medication, you reduce the risk of weight regain and the associated frustration of having to lose the same weight again